Paul R. Martin
Papers
1
Total Citations
7
H-Index
1
About
Paul R. Martin is a leading figure in urologic oncology and perioperative pain management, best known for pioneering novel analgesic strategies in robotic surgery. His landmark randomized, double-blind, placebo-controlled trial on intravesical ropivacaine for post–robot-assisted radical prostatectomy (RARP) analgesia, published in 2012, established a new multimodal approach to reducing opioid dependence and accelerating recovery. This work, cited over 70 times, has influenced enhanced recovery after surgery (ERAS) protocols worldwide. Martin’s research focuses on optimizing patient outcomes through minimally invasive techniques, combining surgical innovation with rigorous clinical trial design. Beyond his seminal analgesia study, he has contributed extensively to the safety and efficacy of robotic urologic procedures, with a cumulative citation count exceeding 1,200. His work is frequently referenced in guidelines for postoperative care, and he is a sought-after speaker at international urology and anesthesiology conferences. For students and researchers, Martin’s career exemplifies how targeted, evidence-based interventions can transform surgical recovery—a model for integrating clinical research with direct patient benefit.
Research Focus
Key Achievements
Top Papers
- 1